|
Issue Open Date
|
10-Dec-25
|
|
Issue Closing Date
|
12-Dec-25
|
|
Application Money
|
100
|
|
Allotment Money
|
|
|
|
Price Band
|
438
-
460
|
|
Minimium Application No.
|
32
|
|
Issue Size (Shares)
|
13387854
|
|
Market Lot
|
1
|
|
|
|
|
Objective
|
|
1. Capital expenditure by our Company for opening new dialysis clinics in India and;2. Pre-payment, or scheduled repayment, in full or part, of certain borrowings availed by our Company; and 3. General corporate purposes.
|
|
|
|
|
|
|
Category
|
No. of Shares
|
No. of Shares
|
Subscription Ratio
|
|
|
Offered / Reserved |
Bid For |
|
|
Non-Institutional Investors
|
2886270
|
70051008
|
24.27
|
|
Qualified Institutional Buyers
|
3678793
|
101069088
|
27.47
|
|
Retail Individual Investors
|
3678793
|
101069088
|
27.47
|
|
|
|
|
Business Description
We offer comprehensive dialysis care through our network of clinics – from diagnosis to treatment and wellnessprograms including haemodialysis, home and mobile dialysis, supported by pharmacy. We are India’s largestdialysis service provider in terms of number
|
|
|
Promoter's Holding
|
|
Total Share Capital
|
|
|
Offered to Public
|
18935819
|
|
Promoter's Holding (Pre-Issue)
|
|
|
Promoter's Holding (Post-Issue)
|
|
|
|
MORE > |
|
|
|
|
|
|
|
|
Address |
5th Floor
D Block
Ilabs Centre
Plot 18
Software Units Layout
Survey No. 64
Madhapur
Shaikpet
Hyderabad
,
Telangana
,
500081
Phone :
040 4240 8039
Email :
cs@nephroplus.com
Website :
www.nephroplus.com
|
|
|
|
Registrar |
KFIN Technologies Ltd.
301
The Centrium
3rd Floor
57
Lal Bahadur Shastri Road
Nav Pada
Kurla (West)
Mumbai
|
|
|
|
Listed at |
|
BSE, NSE
|
|
|
|
Lead Manager |
Ambit Pvt Ltd.
ICICI Securities Ltd
IIFL Capital Services Ltd.
Nomura Financial Advisory & Securities (India) Pvt Ltd.
|
|
|
|
Promoters |
Bessemer Venture Partners Trust
Edoras Investment Holdings PTE. Ltd.
HEALTHCARE PARENT Ltd.
Investcorp Growth Opportunity Fund
Investcorp PVT Equity Fund II
Vikram Vuppala
|
|